Ikwegbue Paul Chukwudi, Masamba Priscilla, Oyinloye Babatunji Emmanuel, Kappo Abidemi Paul
Biotechnology and Structural Biochemistry (BSB) Group, Department of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa 3886, South Africa.
Department of Biochemistry, Afe Babalola University, PMB 5454, Ado-Ekiti 360001, Nigeria.
Pharmaceuticals (Basel). 2017 Dec 23;11(1):2. doi: 10.3390/ph11010002.
Heat shock proteins (HSPs) play cytoprotective activities under pathological conditions through the initiation of protein folding, repair, refolding of misfolded peptides, and possible degradation of irreparable proteins. Excessive apoptosis, resulting from increased reactive oxygen species (ROS) cellular levels and subsequent amplified inflammatory reactions, is well known in the pathogenesis and progression of several human inflammatory diseases (HIDs) and cancer. Under normal physiological conditions, ROS levels and inflammatory reactions are kept in check for the cellular benefits of fighting off infectious agents through antioxidant mechanisms; however, this balance can be disrupted under pathological conditions, thus leading to oxidative stress and massive cellular destruction. Therefore, it becomes apparent that the interplay between oxidant-apoptosis-inflammation is critical in the dysfunction of the antioxidant system and, most importantly, in the progression of HIDs. Hence, there is a need to maintain careful balance between the oxidant-antioxidant inflammatory status in the human body. HSPs are known to modulate the effects of inflammation cascades leading to the endogenous generation of ROS and intrinsic apoptosis through inhibition of pro-inflammatory factors, thereby playing crucial roles in the pathogenesis of HIDs and cancer. We propose that careful induction of HSPs in HIDs and cancer, especially prior to inflammation, will provide good therapeutics in the management and treatment of HIDs and cancer.
热休克蛋白(HSPs)在病理条件下通过启动蛋白质折叠、修复、错误折叠肽段的重折叠以及对无法修复的蛋白质进行可能的降解来发挥细胞保护活性。由细胞内活性氧(ROS)水平升高以及随后放大的炎症反应导致的过度凋亡,在几种人类炎症性疾病(HIDs)和癌症的发病机制及进展过程中是众所周知的。在正常生理条件下,ROS水平和炎症反应通过抗氧化机制受到控制,以实现抵御感染因子的细胞益处;然而,这种平衡在病理条件下可能会被打破,从而导致氧化应激和大量细胞破坏。因此,氧化剂 - 凋亡 - 炎症之间的相互作用在抗氧化系统功能障碍中,尤其是在HIDs的进展中至关重要这一点变得显而易见。因此,有必要在人体氧化剂 - 抗氧化剂 - 炎症状态之间保持谨慎的平衡。已知HSPs通过抑制促炎因子来调节炎症级联反应的效应,从而导致ROS的内源性产生和内在凋亡,因此在HIDs和癌症的发病机制中发挥关键作用。我们提出,在HIDs和癌症中谨慎诱导HSPs,尤其是在炎症发生之前,将为HIDs和癌症的管理与治疗提供良好的治疗方法。